CLINICAL_TRIALS
research
· 2014-05-30
Clinical Trial Update: StahistRx Phase 2, Five-arm, Parallel Group, Active vs Active, Double-blind Study [Phase 2]
Summary
Phase 2, five-arm, parallel-group, double-blind study evaluating StahistRx for seasonal allergic rhinitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Magna Pharmaceuticals, Inc. | Conditions: Rhinitis, Seasonal, Allergic | Phase 2 | Status: UNKNOWN